160 related articles for article (PubMed ID: 4467221)
1. [Minimal inhibitory concentration in hospital bacteria].
Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
[No Abstract] [Full Text] [Related]
2. [Present frequency of the different Serratia species isolated in Grenoble University Hospital Center (author's transl)].
Croize J; Le Noc P
Pathol Biol (Paris); 1977 Nov; 25(9):617-21. PubMed ID: 341050
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of six quinolone antibacterials (author's transl)].
Soussy CJ; Thibault M; Kitzis MD; Acar JF; Duval J; Chabbert YA
Ann Microbiol (Paris); 1977 Jul; 128B(1):19-33. PubMed ID: 907268
[No Abstract] [Full Text] [Related]
5. [In vitro action of oxolinic acid in comparison with nitrofurantoin and nalidixic acid].
Grima P
Minerva Urol; 1977; 29(5):225-7. PubMed ID: 611403
[No Abstract] [Full Text] [Related]
6. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
Langsádl L; Menkyna R; Golier J; Silan L
Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
[No Abstract] [Full Text] [Related]
7. Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
Gilis PM; Haemers A; Pattyn SR
Antimicrob Agents Chemother; 1978 Mar; 13(3):533-5. PubMed ID: 263890
[TBL] [Abstract][Full Text] [Related]
8. [Modification of the sensitivity of gram-negative strains to chemotherapeutic agents].
De Rosa M; Fera MT; Focà A
G Ital Chemioter; 1977; 24(1-2):99-102. PubMed ID: 615770
[No Abstract] [Full Text] [Related]
9. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
de Rautlin de la Roy Y; Toma V; Bobin B
Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic sensitivity of microbial strains isolated from the hospital environment].
Debeleac L; Voicescu V; Dumitrescu MR; Covacu A; Slavov N; Georgescu M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(3):225-34. PubMed ID: 3438652
[No Abstract] [Full Text] [Related]
11. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
Bertolini A; Castelli M; Genedani S; Garuti M
Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
[TBL] [Abstract][Full Text] [Related]
12. [Microbial sensitivity to various antibacterials, including nalidixic acid. 2,458 Gram negative bacilli strains of diverse origins, especially urinary].
Chamfeuil R; Curcier H
Therapeutique; 1969 Oct; 45(8):757-62. PubMed ID: 5386084
[No Abstract] [Full Text] [Related]
13. Antibacterial activity of miloxacin.
Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
[TBL] [Abstract][Full Text] [Related]
14. [Salmonella typhi epidemic (Mexico, 1972). In vitro sensitivity to various antimicrobial agents].
Luna Castro M; Escarzaga E; Zúñiga V; Gutiérrez M; Ruíz Muñóz J
Prensa Med Mex; 1972; 37(7):256-8. PubMed ID: 4486193
[No Abstract] [Full Text] [Related]
15. In vitro synergism of nalidixic acid with other broad spectrum antibiotics.
Piccolomini R; Cellini L; Allocati N; Ravagnan G
Chemioterapia; 1984 Apr; 3(2):103-7. PubMed ID: 6532536
[TBL] [Abstract][Full Text] [Related]
16. Survey of antibiotic resistance in an integrated marine aquaculture system under oxolinic acid treatment.
Giraud E; Douet DG; Le Bris H; Bouju-Albert A; Donnay-Moreno C; Thorin C; Pouliquen H
FEMS Microbiol Ecol; 2006 Mar; 55(3):439-48. PubMed ID: 16466383
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of antibacterial activity of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon) in vitro and in patients with urinary tract infections].
Manitius A; Hebanowski M; Galiński J; Nowicki B
Pol Tyg Lek; 1978 Aug; 33(34):1347-50. PubMed ID: 704439
[No Abstract] [Full Text] [Related]
18. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
Greenwood D
Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity-pattern of gram-negative pathogens towards nalidixic acid.
Banerjee PL; Arya SC
Indian J Med Res; 1968 Nov; 56(11):1638-42. PubMed ID: 5715963
[No Abstract] [Full Text] [Related]
20. [Variations in vitro of the efficacy of quinolones as a function of pH].
François B; Gille Y; Schmuck N; Assenat H; Adeleine P; Davoine P
Nephrologie; 1983; 4(6):259-62. PubMed ID: 6669186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
